BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36349755)

  • 1. Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer.
    Ohashi A; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Fujishiro M
    Digestion; 2022; 103(6):451-461. PubMed ID: 36349755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces.
    Zhong X; Wang Y; Xu J; Cao H; Zhang F; Wang X
    Front Cell Infect Microbiol; 2022; 12():1054808. PubMed ID: 36704106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon.
    Zorron Cheng Tao Pu L; Yamamoto K; Honda T; Nakamura M; Yamamura T; Hattori S; Burt AD; Singh R; Hirooka Y; Fujishiro M
    J Gastroenterol Hepatol; 2020 Mar; 35(3):433-437. PubMed ID: 31609493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.
    Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y
    Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.
    Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M
    BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Regional Specificity of Mucosa-Associated Microbiota in Patients with Distal Colorectal Cancer.
    Kono Y; Inoue R; Teratani T; Tojo M; Kumagai Y; Morishima S; Koinuma K; Lefor AK; Kitayama J; Sata N; Horie H
    Digestion; 2022; 103(2):141-149. PubMed ID: 34619680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer.
    Shah MS; DeSantis T; Yamal JM; Weir T; Ryan EP; Cope JL; Hollister EB
    PLoS One; 2018; 13(11):e0207002. PubMed ID: 30412600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
    Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
    Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosa-associated microbiota signature in colorectal cancer.
    Gao R; Kong C; Huang L; Li H; Qu X; Liu Z; Lan P; Wang J; Qin H
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2073-2083. PubMed ID: 28600626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota profiles in feces and paired tumor and non-tumor tissues from Colorectal Cancer patients. Relationship to the Body Mass Index.
    Tesolato S; Ortega-Hernández A; Gómez-Garre D; Claver P; De Juan C; De la Serna S; Paz M; Domínguez-Serrano I; Dziakova J; Rivera D; Torres A; Iniesta P
    PLoS One; 2023; 18(10):e0292551. PubMed ID: 37796924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crypt- and Mucosa-Associated Core Microbiotas in Humans and Their Alteration in Colon Cancer Patients.
    Saffarian A; Mulet C; Regnault B; Amiot A; Tran-Van-Nhieu J; Ravel J; Sobhani I; Sansonetti PJ; Pédron T
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut mucosal microbiota profiles linked to colorectal cancer recurrence.
    Huo RX; Wang YJ; Hou SB; Wang W; Zhang CZ; Wan XH
    World J Gastroenterol; 2022 May; 28(18):1946-1964. PubMed ID: 35664963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota Signatures in Tumor, Para-Cancerous, Normal Mucosa, and Feces in Colorectal Cancer Patients.
    Li Y; Cao H; Fei B; Gao Q; Yi W; Han W; Bao C; Xu J; Zhao W; Zhang F
    Front Cell Dev Biol; 2022; 10():916961. PubMed ID: 35721506
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the structure of intestinal mucosal flora in colorectal cancer patients].
    Hu M; Chen K; Wang N; Zhao Y; Wei C; Meng L; Tang Y; Teng Y; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Feb; 42(2):263-271. PubMed ID: 35365452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
    Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
    J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Comparison of Fecal Microbiota in Left-Side and Right-Side Human Colorectal Cancer.
    Miyake T; Mori H; Yasukawa D; Hexun Z; Maehira H; Ueki T; Kojima M; Kaida S; Iida H; Shimizu T; Ohno M; Andoh A; Tani M
    Eur Surg Res; 2021; 62(4):248-254. PubMed ID: 34198297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal and Tissue Microbiota Are Associated with Tumor T-Cell Infiltration and Mesenteric Lymph Node Involvement in Colorectal Cancer.
    Luu K; Ye JY; Lagishetty V; Liang F; Hauer M; Sedighian F; Kwaan MR; Kazanjian KK; Hecht JR; Lin AY; Jacobs JP
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.
    Kasai C; Sugimoto K; Moritani I; Tanaka J; Oya Y; Inoue H; Tameda M; Shiraki K; Ito M; Takei Y; Takase K
    Oncol Rep; 2016 Jan; 35(1):325-33. PubMed ID: 26549775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study.
    Amitay EL; Werner S; Vital M; Pieper DH; Höfler D; Gierse IJ; Butt J; Balavarca Y; Cuk K; Brenner H
    Carcinogenesis; 2017 Aug; 38(8):781-788. PubMed ID: 28582482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.